F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.

Dedeurwaerdere, S
Gregoire, MC
Vivash, L
Roselt, P
Binns, D
Fookes, CJR
Greguric, I
Pham, TQ
Loc'h, C
Katsifis, A
Hicks, RJ
O'Brien, TJ
Myers, DE

June 2009

Purpose: [11C]Flumazenil shows promise as a clinical and research PET radiotracer to image changes i...

[11C]flumazenil-PET: De benzodiazepinereceptor in beeld

Dijstelbloem, Y. P.
Verschoor, H.
Windhorst, A. D.
Luurtsema, G.
Lammertsma, A. A.
Franssen, E. J F

March 2003

Positron emission tomography (PET) is an imaging technology with clinical applications in diagnostic...

Contribution of neuroinflammation to changes in [C-11]flumazenil binding in the rat brain:Evaluation of the inflamed pons as reference tissue

Parente, Andrea
Vállez García, David
Shoji, Alexandre
Lopes Alves, Isadora
Maas, Bram
Zijlma, Rolf
Dierckx, Rudi A. J. O.
Buchpiguel, Carlos A.
de Vries, Erik F. J.
Doorduin, Janine

June 2017

Introduction: [C-11]Flumazenil is a well-known PET tracer for GABA(A) receptors and is mainly used a...

In vivo measurement of hippocampal GABAA/cBZR density with [18F]-Flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy

Vivash, L
Gregoire, MC
Bouilleret, V
Berard, A
Wimberley, C
Binns, D
Roselt, P
Katsifis, A
Myers, DE
Hicks, RJ
O'Brien, TJ
Dedeurwaerdere, S

January 2014

Purpose Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the ...

In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [F-18]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

Vivash, L
Gregoire, M-C
Bouilleret, V
Berard, A
Wimberley, C
Binns, D
Roselt, P
Katsifis, A
Myers, DE
Hicks, RJ
O'Brien, TJ
Dedeurwaerdere, S

January 2014

PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the...

In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Lucy Vivash
Marie-Claude Gregoire
Viviane Bouilleret
Alexis Berard
Catriona Wimberley
David Binns
Peter Roselt
Andrew Katsifis
Damian E Myers
Rodney J Hicks
Terence J O'Brien
Stefanie Dedeurwaerdere

PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the...

18F-Flumazenil: A g-Aminobutyric Acid A–Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy

Lucy Vivash
Marie-claude Gregoire
Eddie W. Lau
Robert E. Ware
David Binns
Peter Roselt
Viviane Bouilleret
Damian E. Myers
Mark J. Cook
Rodney J. Hicks
Terence J. O’brien

September 2016

localizes the epileptogenic zone in patients with medically refractory focal epilepsy than 18F-FDG P...

18F-Flumazenil: A g-Aminobutyric Acid A–Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy

Lucy Vivash
Marie-claude Gregoire
Eddie W. Lau
Robert E. Ware
David Binns
Peter Roselt
Viviane Bouilleret
Damian E. Myers
Mark J. Cook
Rodney J. Hicks
Terence J. O’brien

September 2016

localizes the epileptogenic zone in patients with medically refractory focal epilepsy than 18F-FDG P...

[18F]-Flumazenil: A γ-aminobutyric acid A–specific PET radiotracer for the localisation of drug resistant temporal lobe epilepsy

Vivash, L
Gregoire, MC
Lau, EW
Ware, RE
Binns, D
Roselt, P
Bouilleret, V
Myers, DE
Cook, MJ
Hicks, RJ
O’Brien, TJ

December 2014

Studies report that 11C-flumazenil (FMZ) PET more specifically localizes the epileptogenic zone in p...

Development of [18F]-Flumazenil-PET for localisation of the epileptogenic zone in patients with medically refractory focal epilepsy.

Vivash, L
Gregoire, MC
Dedeurwaerdere, S
Bouilleret, V
Roselt, P
Lau, EW
Ware, RE
Binns, D
Katsifis, A
Hicks, RJ
Myers, DE
O'Brien, TJ

October 2010

Introduction: Studies of GABAA/central benzodiazepine receptor (GABAA/cBZR) distribution in the CNS ...

The development of [18F]-flumazenil PET for the localisation of the epileptogenic zone in patients with focal epilepsy

Vivash, Lucy Elizabeth

January 2012

Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents

Daniel Labarb
Bernard Galleza

February 2015

Pre-clinical studies were carried out in order to characterize in rodents the biodistribution, the b...

Population pharmacokinetic analysis for simultaneous determination of Bmax and KD In Vivo by positron emission tomography

Liefaard, Lia C.
Ploeger, Bart A.
Molthoff, Carla F.M.
Boellaard, Ronald
Lammertsma, Adriaan A.
Danhof, Meindert
Voskuyl, Rob A.

November 2005

Purpose: Changes in GABAA-receptor density and affinity play an important role in many forms of epil...

Biological properties of 2′-[18F]fluoroflumazenil for central benzodiazepine receptor imaging

강원준

January 2005

A novel positron emitting agent, 2′-[18F]fluoroflumazenil (fluoroethyl 8-fluoro-5-methyl-6-oxo-5,6-d...

Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents.

Levêque, Philippe
Labar, Daniel
Gallez, Bernard

January 2001

Pre-clinical studies were carried out in order to characterize in rodents the biodistribution, the b...

In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.

Dedeurwaerdere, S
Gregoire, MC
Vivash, L
Roselt, P
Binns, D
Fookes, CJR
Greguric, I
Pham, TQ
Loc'h, C
Katsifis, A
Hicks, RJ
O'Brien, TJ
Myers, DE

June 2009

Purpose: [11C]Flumazenil shows promise as a clinical and research PET radiotracer to image changes i...

[11C]flumazenil-PET: De benzodiazepinereceptor in beeld

Dijstelbloem, Y. P.
Verschoor, H.
Windhorst, A. D.
Luurtsema, G.
Lammertsma, A. A.
Franssen, E. J F

March 2003

Positron emission tomography (PET) is an imaging technology with clinical applications in diagnostic...

Contribution of neuroinflammation to changes in [C-11]flumazenil binding in the rat brain:Evaluation of the inflamed pons as reference tissue

Parente, Andrea
Vállez García, David
Shoji, Alexandre
Lopes Alves, Isadora
Maas, Bram
Zijlma, Rolf
Dierckx, Rudi A. J. O.
Buchpiguel, Carlos A.
de Vries, Erik F. J.
Doorduin, Janine

June 2017

Introduction: [C-11]Flumazenil is a well-known PET tracer for GABA(A) receptors and is mainly used a...

In vivo measurement of hippocampal GABAA/cBZR density with [18F]-Flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy

Vivash, L
Gregoire, MC
Bouilleret, V
Berard, A
Wimberley, C
Binns, D
Roselt, P
Katsifis, A
Myers, DE
Hicks, RJ
O'Brien, TJ
Dedeurwaerdere, S

January 2014

Purpose Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the ...

In Vivo Measurement of Hippocampal GABA(A)/cBZR Density with [F-18]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

Vivash, L
Gregoire, M-C
Bouilleret, V
Berard, A
Wimberley, C
Binns, D
Roselt, P
Katsifis, A
Myers, DE
Hicks, RJ
O'Brien, TJ
Dedeurwaerdere, S

January 2014

PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the...

In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Lucy Vivash
Marie-Claude Gregoire
Viviane Bouilleret
Alexis Berard
Catriona Wimberley
David Binns
Peter Roselt
Andrew Katsifis
Damian E Myers
Rodney J Hicks
Terence J O'Brien
Stefanie Dedeurwaerdere

PURPOSE: Imbalance of inhibitory GABAergic neurotransmission has been proposed to play a role in the...

18F-Flumazenil: A g-Aminobutyric Acid A–Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy

Lucy Vivash
Marie-claude Gregoire
Eddie W. Lau
Robert E. Ware
David Binns
Peter Roselt
Viviane Bouilleret
Damian E. Myers
Mark J. Cook
Rodney J. Hicks
Terence J. O’brien

September 2016

localizes the epileptogenic zone in patients with medically refractory focal epilepsy than 18F-FDG P...

18F-Flumazenil: A g-Aminobutyric Acid A–Specific PET Radiotracer for the Localization of Drug-Resistant Temporal Lobe Epilepsy

Lucy Vivash
Marie-claude Gregoire
Eddie W. Lau
Robert E. Ware
David Binns
Peter Roselt
Viviane Bouilleret
Damian E. Myers
Mark J. Cook
Rodney J. Hicks
Terence J. O’brien

September 2016

localizes the epileptogenic zone in patients with medically refractory focal epilepsy than 18F-FDG P...

[18F]-Flumazenil: A γ-aminobutyric acid A–specific PET radiotracer for the localisation of drug resistant temporal lobe epilepsy

Vivash, L
Gregoire, MC
Lau, EW
Ware, RE
Binns, D
Roselt, P
Bouilleret, V
Myers, DE
Cook, MJ
Hicks, RJ
O’Brien, TJ

December 2014

Studies report that 11C-flumazenil (FMZ) PET more specifically localizes the epileptogenic zone in p...

Development of [18F]-Flumazenil-PET for localisation of the epileptogenic zone in patients with medically refractory focal epilepsy.

Vivash, L
Gregoire, MC
Dedeurwaerdere, S
Bouilleret, V
Roselt, P
Lau, EW
Ware, RE
Binns, D
Katsifis, A
Hicks, RJ
Myers, DE
O'Brien, TJ

October 2010

Introduction: Studies of GABAA/central benzodiazepine receptor (GABAA/cBZR) distribution in the CNS ...

The development of [18F]-flumazenil PET for the localisation of the epileptogenic zone in patients with focal epilepsy

Vivash, Lucy Elizabeth

January 2012

Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents

Daniel Labarb
Bernard Galleza

February 2015

Pre-clinical studies were carried out in order to characterize in rodents the biodistribution, the b...

Population pharmacokinetic analysis for simultaneous determination of Bmax and KD In Vivo by positron emission tomography

Liefaard, Lia C.
Ploeger, Bart A.
Molthoff, Carla F.M.
Boellaard, Ronald
Lammertsma, Adriaan A.
Danhof, Meindert
Voskuyl, Rob A.

November 2005

Purpose: Changes in GABAA-receptor density and affinity play an important role in many forms of epil...

Biological properties of 2′-[18F]fluoroflumazenil for central benzodiazepine receptor imaging

강원준

January 2005

A novel positron emitting agent, 2′-[18F]fluoroflumazenil (fluoroethyl 8-fluoro-5-methyl-6-oxo-5,6-d...

Biodistribution, binding specificity and metabolism of [18F]fluoroethylflumazenil in rodents.

Levêque, Philippe
Labar, Daniel
Gallez, Bernard

January 2001

Pre-clinical studies were carried out in order to characterize in rodents the biodistribution, the b...

In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat.

Dedeurwaerdere, S
Gregoire, MC
Vivash, L
Roselt, P
Binns, D
Fookes, CJR
Greguric, I
Pham, TQ
Loc'h, C
Katsifis, A
Hicks, RJ
O'Brien, TJ
Myers, DE

June 2009

Purpose: [11C]Flumazenil shows promise as a clinical and research PET radiotracer to image changes i...

[11C]flumazenil-PET: De benzodiazepinereceptor in beeld

Dijstelbloem, Y. P.
Verschoor, H.
Windhorst, A. D.
Luurtsema, G.
Lammertsma, A. A.
Franssen, E. J F

March 2003

Positron emission tomography (PET) is an imaging technology with clinical applications in diagnostic...

Contribution of neuroinflammation to changes in [C-11]flumazenil binding in the rat brain:Evaluation of the inflamed pons as reference tissue

Parente, Andrea
Vállez García, David
Shoji, Alexandre
Lopes Alves, Isadora
Maas, Bram
Zijlma, Rolf
Dierckx, Rudi A. J. O.
Buchpiguel, Carlos A.
de Vries, Erik F. J.
Doorduin, Janine

June 2017

Introduction: [C-11]Flumazenil is a well-known PET tracer for GABA(A) receptors and is mainly used a...

F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

Abstract

Extracted data

F]-Flumazenil PET for the Study of Disease Progression in an Animal Model of Temporal Lobe Epilepsy

Abstract

Extracted data

Related items

Related items